Results 111 to 120 of about 25,511 (229)

Rubella serosurveys at three Aravind Eye Hospitals in Tamil Nadu, India

open access: yesBulletin of the World Health Organization, 2004
OBJECTIVE: To determine the susceptibility of female eye hospital staff to rubella infection and the potential risk for hospital-based rubella outbreaks. METHODS: A prospective cohort study on the seroprevalence of rubella IgG antibodies was conducted at
Vijayalakshmi Perumalsamy   +7 more
doaj  

MMR vaccine (measles, mumps, rubella) : what you need to know [Pashto]

open access: yes
MMR vaccine (measles, mumps, rubella) : what you need to know [Pashto]MMR VIS \u2013 Pashto (8/6/21)pashto_mmr ...

core  

Rubella Vaccine -- 1967-68 -- Correspondence, General -- letter, 1967-08-08

open access: yes, 1967
Letter from Stewart, Richard C. to Sabin, Albert B. dated 1967-08-08.Sabin Collection Fair Use PolicyIncludes document titled, "Immunization Against Rubella with Living Virus: III.
Stewart, Richard C.
core  

MMR vaccine (measles, mumps, rubella) : what you need to know [Dari]

open access: yes
MMR vaccine (measles, mumps, rubella) : what you need to know [Dari]MMR VIS \u2013 Dari (8/6/21)dari_mmr ...

core  

Understanding MMR vaccine safety [PDF]

open access: yes
Last updated February 2013CDC recommends two doses of the measles, mumps, and rubella vaccine (MMR) for children because it protects them against dangerous, even deadly, diseases.CS233434Nvacsafe-mmr-color-office ...

core  

Microtitration of Rubella Virus in Monovalent Vaccinal Products

open access: yesIranian Journal of Public Health, 2011
Background: Potency test for control of rubella vaccine is a significant factor to qualify production line and vaccination pro­gram. For this reason, WHO recommends to use the microtitration method by both vaccine companies and control laborato­ries ...
F Esna-Ashari   +9 more
doaj  

Seroconversion of a trivalent measles, mumps, and rubella vaccine in children aged 9 and 15 months

open access: yes, 1997
The serological response to MMR vaccine was evaluated in 109 9-month-old infants having no history of measles vaccination, and in 98 15-month-old children who had received monocomponent measles immunisation at 9 months.
Forleo, LHA   +5 more
core   +1 more source

Safety of measles, mumps, and rubella vaccine in adolescents and adults in the vaccine safety Datalink. [PDF]

open access: yesVaccine X, 2023
Hanson KE   +11 more
europepmc   +1 more source

MMR vaccine (measles, mumps, rubella) : what you need to know [Arabic]

open access: yes
MMR vaccine (measles, mumps, rubella) : what you need to know [Arabic]MMR VIS \u2013 Arabic (8/6/21)arabic_mmr ...

core  

Measles, mumps and rubella vaccine 12 months after hematopoietic stem cell transplantation. [PDF]

open access: yesRev Inst Med Trop Sao Paulo, 2023
Randi BA   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy